Aclaris Therapeutics
ACRS | NASDAQ
$3.60
-$0.32 (-8.16%)
At close: Nov 16, 2026, 4:00 PM ET
$3.66
+$0.06 (+1.66%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Aclaris Therapeutics Statistics
Key statistics explainedMarket Data
$571.8M
$457.5M
0.80
2.67M
149.45M
21.88%
83.71%
NASDAQ
US00461U1051
Price Performance
9.8%
-39.2%
-18.2%
19.6%
46.9%
277.2%
-74.0%
9.8%
42.9%
-22.7%
-15.5%
Valuation
-6.21
N/A
-0.14
-0.47
89.33
109.90
3.43
-7.60
-6.57
-7.20
71.47
-7.48
-5.57
-6.08
-16.1%
-13.2%
-15.2%
Financial Health
$114.29M
$0
$204.61M
$216.16M
5.09
5.09
0.00
-0.00
-0.00
N/A
0.00
0.55
4
Margins & Profitability
99.8%
-1414.0%
-1237.7%
-1244.1%
-1175.3%
-1359.9%
184.6%
-15.7%
Returns
-36.8%
-59.2%
-47.2%
-47.2%
-36.8%
Historical Growth (CAGR)
-33.2%
-1.3%
10.7%
-3.6%
14.9%
16.2%
-49.1%
-0.9%
1.0%
Analyst Forecasts
Buy
4
-14.4%
49.0%
Feb 25, 2027
-$0.13
-18.8%
$1.37M
5.9%
Fair Value Estimates
N/A
N/A
N/A
N/A
$9.50
163.9%
Cash Flow
$-75.21M
$-75.23M
$-87.05M
-$0.50
-$0.50
-1174.9%
Income Statement
$6.4M
$6.39M
$-90.51M
$-82.16M
$-79.63M
-$0.58
$90.15K
$-1.12M
71
Add to Watchlist
Select watchlists to add or remove ACRS